Predictive Oncology Inc. — Director's Dealing 2025

Dec 3, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Predictive Oncology Inc. (POAI)
CIK: 0001446159
Period of Report: 2025-11-28

Reporting Person: Vennare Raymond F (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-11-28	Common Stock	F	2373	$5.90	Disposed	6418	Direct

Footnotes

F1: On September 9, 2025, Reporting Person was granted 8,331 restricted stock units ("RSUs"). Each RSU represented the right to receive one share of common stock upon vesting. The RSUs vested in full on October 31, 2025 and were settled on November 28, 2025. 2,373 shares of common stock were withheld by the Issuer on November 28, 2025 to cover withholding tax, in accordance with the Restricted Stock Unit Award Agreement between Reporting Person and the Company.